Glimepiride recalls

Glimepiride products have been recalled 8 times, most recently on 14 Feb 2024. The recalling company is usually Accord Healthcare. The most common reason is manufacturing (cgmp) deviations.

Total recalls8since 2014

Last 12 months0reported

Class I00% of total

Ongoing4latest 14 Feb 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 6 75%Class III 2 25%

Why glimepiride is recalled

Companies

Product types

Diabetes Medication8100%

By year

2024225%
2023563%
2014113%

Ongoing glimepiride recalls

4 active

Reported	Class	Recall	Company	Reason	Where
14 Feb 2024Drug	CLASS III	Glimepiride Tablets, USP 1mg recalled by Dr. Reddy's LaboratoriesGlimepiride	Dr. Reddy's Laboratories	Other	Nationwide
14 Feb 2024Drug	CLASS III	Glimepiride Tablets, USP 1mg recalled by Dr. Reddy's LaboratoriesGlimepiride	Dr. Reddy's Laboratories	Other	Nationwide
3 May 2023Drug	CLASS II	Glimepiride Tablets, USP 4mg recalled by Northwind PharmaceuticalsGlimepiride	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 May 2023Drug	CLASS II	Glimepiride Tablets, USP 2mg recalled by Northwind PharmaceuticalsGlimepiride	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide

All glimepiride recalls, newest first

8 total

Reported	Class	Recall	Company	Reason	Where
14 Feb 2024Drug	CLASS III	Glimepiride Tablets, USP 1mg recalled by Dr. Reddy's LaboratoriesGlimepiride	Dr. Reddy's Laboratories	Other	Nationwide
14 Feb 2024Drug	CLASS III	Glimepiride Tablets, USP 1mg recalled by Dr. Reddy's LaboratoriesGlimepiride	Dr. Reddy's Laboratories	Other	Nationwide
3 May 2023Drug	CLASS II	Glimepiride Tablets, USP 4mg recalled by Northwind PharmaceuticalsGlimepiride	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 May 2023Drug	CLASS II	Glimepiride Tablets, USP 2mg recalled by Northwind PharmaceuticalsGlimepiride	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
8 Mar 2023Drug	CLASS II	Glimepiride Tablets USP, 4 mg recalled by Accord HealthcareGlimepiride	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
8 Mar 2023Drug	CLASS II	Glimepiride Tablets USP, 2 mg recalled by Accord HealthcareGlimepiride	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
8 Mar 2023Drug	CLASS II	Glimepiride Tablets USP, 1 mg recalled by Accord HealthcareGlimepiride	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
5 Nov 2014Drug	CLASS II	Glimepiride Tablets, USP 2 mg, a) recalled by Micro Labs Usa, Inc SGlimepiride	Micro Labs Usa, Inc S	Potency & Assay	5 states

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.